Clinical Management of Potential Toxicity of Abemaciclib and Approaches to Ensure Treatment Continuation

INTRODUCTION: The association between abemaciclib dose reduction and treatment adherence is not clear. In this study, we examined real-world data of Japanese patients with advanced breast cancer (ABC) to determine how abemaciclib dose reduction is related to treatment continuation. METHODS: This ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, Shinya, Maeda, Hideki, Umehara, Kengo, Kuwahara, Sayuri, Yamamoto, Mitsugu, Tomioka, Nobumoto, Takahashi, Masato, Watanabe, Kenichi, Hashishita, Hirokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505863/
https://www.ncbi.nlm.nih.gov/pubmed/37378924
http://dx.doi.org/10.31557/APJCP.2023.24.6.1955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505863/
https://www.ncbi.nlm.nih.gov/pubmed/37378924
http://dx.doi.org/10.31557/APJCP.2023.24.6.1955

Ejemplares similares